THE INNOVATIVE MEDICINES INITIATIVE
The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients.
IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.
IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA.
IMI 10TH CALL LAUNCHED
IMI has launched its 10th Call for proposals with a topic on Immunological assay standardisation & development for use in assessments of correlates of protection for influenza vaccines.
Deadline for applications: 28 January 2014
- 03/12/2013 : RT @EUCouncilPress: Council adopts #Horizon2020: the EU's #research and #innovation programme for 2014-2020: http://t.co/gk7gHxxlFI.
- 03/12/2013 : RT @GiuliaPigi: Dr Andy Wells presenting an overview on #CHEM21 at Delhi networking event. Exciting times! @GreenChemYork @IMI_JU http://t.…
- 02/12/2013 : RT @EUCouncilPress: Competitiveness Council to focus on innovative public-private partnerships under #Horizon2020. Preview video: http://t.…